Solid Biosciences, Inc.

... ...
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 2.50%155.730.0%$2772.08m
BNGOBioNano Genomics, Inc. -9.58%11.040.0%$2276.92m
GILDGilead Sciences, Inc. -1.83%65.481.0%$648.92m
AMGNAmgen, Inc. -2.92%251.061.3%$589.46m
ILMNIllumina, Inc. 2.74%432.083.5%$492.29m
REGNRegeneron Pharmaceuticals, Inc. -5.25%515.562.7%$490.42m
ALXNAlexion Pharmaceuticals, Inc. -3.75%155.692.0%$465.97m
CRSPCRISPR Therapeutics AG -3.29%163.950.6%$436.82m
NVAXNovavax, Inc. 3.16%131.1892.9%$414.65m
VRTXVertex Pharmaceuticals, Inc. -5.21%225.251.9%$378.27m
SRPTSarepta Therapeutics, Inc. -2.33%90.4913.8%$340.81m
SRNESorrento Therapeutics, Inc. 46.16%15.231.4%$334.63m
BIIBBiogen, Inc. -2.40%265.151.7%$314.34m
BNTXBioNTech SE -0.30%105.970.0%$293.53m
EXASEXACT Sciences Corp. -2.97%136.8519.6%$253.85m

Company Profile

Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy. It develops gene therapies, disease modifying therapies, and assistive devices for the cure of DMD. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Arnold, Annie Ganot and Gilad David Hayeem in March 2013 and is headquartered in Cambridge, MA.